Lingli Chen Selected Research

fibrin fragment D (D-dimer)

1/2023	Combination of D-dimer and Albumin in the Prediction of Deep Vein Thrombosis in Patients with Spontaneous Intracerebral Hemorrhage.
1/2021	Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
11/2020	A predictive model for the severity of COVID-19 in elderly patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lingli Chen Research Topics

Disease

42	Neoplasms (Cancer) 02/2024 - 11/2008
12	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2008
10	Hepatocellular Carcinoma (Hepatoma) 05/2023 - 01/2009
10	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2013
8	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2019
7	COVID-19 03/2024 - 01/2020
5	Inflammation (Inflammations) 01/2023 - 03/2010
3	Body Weight (Weight, Body) 01/2024 - 01/2018
3	Carcinogenesis 12/2023 - 11/2012
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2017
2	Endometrial Neoplasms (Endometrial Cancer) 02/2024 - 12/2023
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2024 - 04/2021
2	Necrosis 04/2023 - 11/2010
2	Cognitive Dysfunction 01/2023 - 06/2018
2	Adenocarcinoma 01/2023 - 01/2020
2	Ischemic Stroke 01/2023 - 08/2022
2	Infections 01/2023 - 01/2018
2	Stroke (Strokes) 01/2023 - 01/2022
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2022 - 09/2022
2	Type 2 Diabetes Mellitus (MODY) 12/2022 - 09/2022
2	Hypoxia (Hypoxemia) 11/2022 - 01/2020
2	Microsatellite Instability 08/2022 - 01/2022
2	Acute Lung Injury 06/2022 - 06/2022
2	Wounds and Injuries (Trauma) 05/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 01/2018
2	Fibrosis (Cirrhosis) 01/2015 - 01/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015 - 01/2014
2	Lung Neoplasms (Lung Cancer) 11/2012 - 01/2012
2	Primary angiitis of the central nervous system 04/2010 - 03/2010
1	Glycogen Storage Disease Type Ix 04/2024
1	Glycogen Storage Disease IXB 04/2024
1	Glycogen Storage Disease (Glycogenosis) 04/2024
1	Hyperplasia 02/2024
1	Paraganglioma (Paragangliomas) 02/2024
1	Extra-Adrenal Paraganglioma (Paraganglioma, Extra Adrenal) 02/2024

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 08/2022 - 06/2018
7	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2018
6	DNA (Deoxyribonucleic Acid)IBA 06/2011 - 01/2010
5	RNA (Ribonucleic Acid)IBA 03/2024 - 07/2013
5	Messenger RNA (mRNA)IBA 03/2023 - 10/2019
5	AlbuminsIBA 01/2023 - 11/2020
5	Therapeutic UsesIBA 01/2020 - 11/2012
4	CytokinesIBA 01/2024 - 12/2019
4	Tyrosine Kinase InhibitorsIBA 05/2023 - 01/2020
4	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2018 - 09/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2016 - 01/2012
4	Small Interfering RNA (siRNA)IBA 04/2015 - 11/2012
4	Lipid NanoparticlesIBA 09/2013 - 10/2008
4	Docetaxel (Taxotere)FDA Link 11/2010 - 11/2008
3	AntibodiesIBA 05/2023 - 07/2021
3	LipidsIBA 01/2023 - 02/2010
3	EnzymesIBA 01/2023 - 07/2022
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2021
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2022
3	fibrin fragment D (D-dimer)IBA 01/2023 - 11/2020
3	MucinsIBA 10/2022 - 01/2021
3	CurcuminIBA 01/2022 - 03/2015
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 03/2015
3	SurvivinIBA 11/2012 - 09/2012
3	PolymersIBA 06/2011 - 03/2010
2	6-methyladenineIBA 03/2024 - 03/2023
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2020
2	Indicators and Reagents (Reagents)IBA 03/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 09/2022
2	ProteomeIBA 01/2023 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2022
2	NAD (NADH)IBA 12/2022 - 09/2022
2	Uric Acid (Urate)IBA 12/2022 - 09/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2022 - 06/2022
2	LipopolysaccharidesIBA 06/2022 - 06/2022
2	Caspase 3 (Caspase-3)IBA 06/2022 - 01/2020
2	Cell Adhesion MoleculesIBA 06/2022 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2020
2	NivolumabIBA 01/2022 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2021 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2020 - 12/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2008
2	Poloxamer (Poloxamer 407)IBA 09/2015 - 11/2012
2	EstersIBA 04/2015 - 07/2014
2	tocophersolanIBA 09/2013 - 11/2012
1	IA 4IBA 04/2024
1	GlycogenIBA 04/2024
1	Antiviral Agents (Antivirals)IBA 03/2024
1	N-methyladenosineIBA 03/2024
1	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2024
1	somatostatin receptor 2IBA 02/2024
1	Volatile Fatty AcidsIBA 01/2024
1	tazemetostatIBA 12/2023
1	AC1Q3QWBIBA 12/2023

Therapy/Procedure

22	Therapeutics 11/2023 - 10/2008
11	Drug Therapy (Chemotherapy) 01/2020 - 11/2008
4	Immunotherapy 03/2023 - 01/2021
3	Hepatectomy 05/2023 - 07/2021
2	Adjuvant Chemotherapy 01/2022 - 01/2017
2	Artificial Respiration (Mechanical Ventilation) 07/2020 - 01/2020
2	Intravenous Administration 07/2013 - 04/2010
1	Conservative Treatment 02/2024